Three companies were chosen to cultivate medical marijuana in Germany.
This is a watershed moment for operations in Germany
We are very proud to have been selected as one of only three companies by the German government, which is a great achievement by our team. Having the highest rated concept is a strong validation of the Aurora Standard cultivation philosophy, as well as of our track record in the delivery of safe and high-quality medical cannabis products to the German system
Aphria Awarded Provisional Approval in Germany for Cannabis Cultivation License
aphria.ca Aphria is proud to have been selected as a successful applicant in the German tender process, a testament to our high production quality standards,” said Hendrik Knopp, Managing Director of Aphria Germany. “The decision from BfArM is a validation of our strategic approach to supporting the German medical cannabis market, including with high-quality, domestic production to secure vital supply for patients. We are very pleased with our continued business momentum in Germany.”
Wayland Selected as One of Three Groups for Cannabis Production Licenses in Germany
From the beginning, the market opportunity for medical cannabis in Germany has been a key part of Wayland’s global growth strategy. The Company has always prioritized Germany as one of the most exciting medical cannabis markets in the world given its progressive regulations, rapidly expanding the patient population, and insurance coverage for over sixty per cent (60%) of prescriptions.